1590-1591 / 2437
PAge52
11/20/2017 |
Author
Division
a
Olaf Witt
SIOP LGG 201X
Meta-analysis SIOP LGG pre-clinical working group:
BRAF KIAA fusions type independent prognostics factor
(multivariate analysis: age, location, histology, extend of resection)
Stratify for relevant targeted therapies e.g. BRAF/ MEK inhibitors
Why (biopsy) molecular biomarkers?